Dietary Intervention and Physical Activity in Patients With Heart Failure and Reduced Ejection Fraction

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age30+
SponsorMedical University of Silesia

About this trial

Heart failure with reduced ejection fraction (HFrEF) is frequently associated with abnormalities in body composition, including reduced skeletal muscle mass and sarcopenia, which are independent predictors of reduced exercise tolerance, impaired quality of life, and increased mortality. Despite advances in pharmacological therapy, evidence-based non-pharmacological strategies aimed at preventing muscle mass loss remain limited.

This randomized controlled trial aims to evaluate the effects of dietary intervention based on the DASH diet with high-protein elements, resistance exercise training, and their combination on skeletal muscle mass, functional capacity, echocardiographic parameters, biochemical markers, and quality of life in patients with HFrEF.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • Resistance Exercise

    Behavioral

    The exercise intervention includes resistance training using elastic bands, with instruction and follow-up provided by a medical rehabilitation specialist.

  • Dietary Intervention

    Behavioral

    Individualized 14-day meal plan based on the DASH diet with high-protein components.

Treatment groups

100 Participants
are divided into 4 treatment groups
Group A: Standard medical careNo intervention 0 interventions
Group B: Resistance Exercise TrainingExperimental treatment 1 intervention
Group C: Dietary InterventionExperimental treatment 1 intervention
Group D: Combined Dietary and Exercise InterventionExperimental treatment 2 interventions

Trial outcomes

Primary outcomes

1

Change in skeletal muscle mass

Quantitative assessment of skeletal muscle mass change over the study period.

Time frame
Baseline to 6 months

Secondary outcomes

1

Change in quality of life

Assessed using the Minnesota Living With Heart Failure Questionnaire.

Time frame
Baseline to 6 months
2

Change in exercise capacity

Assessed by the 6-minute walk test.

Time frame
Baseline to 6 months
3

Change in echocardiographic parameters of diastolic function

Changes in left ventricular diastolic function assessed by transthoracic echocardiography, including early transmitral inflow velocity (E), the ratio of early to late transmitral inflow velocities (E/A), and early diastolic mitral annular velocity (e').

Time frame
Baseline to 6 months
4

Change in laboratory biomarkers

Includes NT-proBNP, HbA1c, K+ creatine, triglycerides, cholesterol,

Time frame
Baseline to 6 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.